Form D · Biotechnology
Dren Bio, Inc.
Foster City, CA · CIK 0001783374
Offering snapshot reported Mar 29, 2022 · SEC filing
- Reported sold
- $62.5M Offering amount: $80M
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 16, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 29, 2022 | Initial | $62,500,000 | No comparison | 27 | SEC filing |
| Nov 12, 2020 | Amendment | $25,499,996 | $0vs Sep 8, 2020 | 11 | SEC filing |
| Sep 8, 2020 | Initial | $25,499,996 | No comparison | 11 | SEC filing |
| Jul 26, 2019 | Initial | $5,054,991 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-439416
Source: Form D, filed Mar 29, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sakae Asanuma | Director |
| Rajeev Dadoo | Director |
| Alex Kolicich | Director |
| Chandra Leo | Director |
| Kenneth R Luehrsen | Director |
| Andrew N. Schiff | Director |
| Nenad Tomasevic | Director, Executive |
| Ivan Trifunovich | Director |
| John Wesley | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
384 Foster City Blvd
Foster City, CA, 94404
Foster City, CA, 94404